Reduction of azides to primary amines in substrates bearing labile ester functionality. Synthesis of a PEG-solubilized, "Y"-shaped iminodiacetic acid reagent for preparation of folate-tethered drugs

Organic Letters

Volumn 1, Issue 2, 1999, Pages 179-181

  Lee, Jae Wook ^a   Fuchs, Philip L ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2 (2 (2 AZIDOETHYLOXY)ETHYLOXY)ETHYLOXY)OXAZINE 2,6 DIONE; 4-(2-(2-(2-AZIDOETHYLOXY)ETHYLOXY)ETHYLOXY)OXAZINE-2,6-DIONE; ACID ANHYDRIDE; AMINE; AZIDE; DIGLYCINE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; ESTER; FOLIC ACID; IMINO ACID; MACROGOL DERIVATIVE; OXAZINE DERIVATIVE; PACLITAXEL;

ARTICLE; CHEMISTRY; OXIDATION REDUCTION REACTION; SYNTHESIS;

AMINES; ANHYDRIDES; AZIDES; ESTERS; FOLIC ACID; IMINO ACIDS; INDICATORS AND REAGENTS; OXAZINES; OXIDATION-REDUCTION; PACLITAXEL; POLYETHYLENE GLYCOLS;

EID: 0033614864     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol9905248     Document Type: Article

References (17)

1. Folate-Mediated Multiple Drug Delivery 3. For papers 1 and 2, see: (a) Wang, S.; Luo, J.; Lantrip, D. A.; Waters, D. J.; Mathias, C. J.; Green, M. A.; Fuchs, P. L.; Low, P. S. Bioconjugate Chem. 1997, 8, 673.
2. (b) Luo, J.; Smith, M. D.; Lantrip, D. A.; Wang, S.; Fuchs, P. L. J. Am. Chem. Soc. 1997, 119, 10004.
3. Schwabacher, A. W.; Lane, J. W.; Schiesher, M. W.; Leigh, K. M.; Johnson, C. W. J. Org. Chem. 1998, 63, 1727. We find that the use of 5% HCl in place of phosphoric acid improves the yield of 4 to 90%. For an earlier preparation of 4, see: Bertozzi, C. R.; Bednarski, M. D. J. Org. Chem. 1991, 56, 4326-4329.
4. Schwabacher, A. W.; Lane, J. W.; Schiesher, M. W.; Leigh, K. M.; Johnson, C. W. J. Org. Chem. 1998, 63, 1727. We find that the use of 5% HCl in place of phosphoric acid improves the yield of 4 to 90%. For an earlier preparation of 4, see: Bertozzi, C. R.; Bednarski, M. D. J. Org. Chem. 1991, 56, 4326-4329.
5. All new compounds have been characterized by proton NMR, carbon NMR, exact mass, and/or elemental analysis.
6. Dessolin, M.; Guillerez, M.-G.; Thieriet, N.; Guibe, F.; Loffet, A. Tetrahedron Lett. 1995, 36, 5741.
7. Frisch, B.; Boeckler, C.; Schuber, F. Bioconjugate Chem. 1996, 7, 180.
8. (b) Wentworth, P., Jr.; Vandersteen, A. M.; Janda, K. D. Chem. Commun. 1997, 759.
9. (c) Urpi, F.; Vilarrasa, J. Tetrahedron Lett. 1986, 27, 4623.
10. (d) Schoetzau, T.; Holletz, T.; Cech, D. Chem. Commun. 1996, 387.
11. Greenwald, R. B.; Gilbert, C. W.; Pendri, A.; Conover, C. D.; Xia, J.; Martinez, A. J. Med. Chem. 1996, 39, 424.
12. Alvarez, S. G.; Fisher, G. B.; Singaram, B. Tetrahedron Lett. 1995, 36, 2567.
13. Suzuki, H.; Kawaguchi, T.; Takaoka, K. Bull. Chem. Soc. Jpn. 1986, 59, 665.
14. Hays, D. S.; Fu, G. C. J. Org. Chem. 1998, 63, 2796.
15. (b) Samano, M. C.; Robins, M. J. Tetrahedron Lett. 1991, 32, 6293.
16. Kamal, A.; Rao, N. V.; Laxman, E. Tetrahedron Lett. 1997, 38, 6945.
17. Bartra, M.; Romea, P.; Urpi, F.; Vilarrasa, J. Tetrahedron 1990, 46, 587.